申请人:ISIS Pharmaceuticals, Inc.
公开号:US20040048826A1
公开(公告)日:2004-03-11
Novel 2′-O-alkyl guanosine compounds are provided. In accordance with preferred embodiments compounds having the structure:
1
wherein X is R
1
—(R
2
)
n
;
R
1
is C
3
-C
20
alkyl, C
4
-C
20
alkenyl or C
2
-C
20
alkynyl;
R
2
is halogen, hydroxyl, thiol, keto, carboxyl, nitro, nitroso, nitrile, trifluoromethyl, trifluoromethoxy, O-alkyl, S-alkyl, NH-alkyl, N-dialkyl, O-aryl, S-aryl, NH-aryl, O-aralkyl, S-aralkyl, NH-aralkyl, amino, N-phthalimido, imidazole, azido, hydrazino, hydroxylamino, isocyanato, sulfoxide, sulfone, sulfide, disulfide, silyl, aryl, heterocycle, carbocycle, intercalator, reporter molecule, conjugate, polyamine, polyamide, polyalkylene glycol, polyether, a group that enhances the pharmacodynamic properties of oligonucleotides, or a group that enhances the pharmacokinetic properties of oligonucleotides; and
n is an integer from 0 to about 6, are provided.
本发明提供了新型的2'-O-烷基
鸟苷化合物。根据优选实施例,所提供的化合物具有以下结构:1其中X为R1-(R2)n;R1为C3-C20烷基、C4-C20烯基或C2-C20炔基;R2为卤素、羟基、
硫醇、酮、羧基、硝基、亚硝基、腈、三
氟甲基、三
氟甲氧基、O-烷基、S-烷基、NH-烷基、N-二烷基、O-芳基、S-芳基、NH-芳基、O-芳基烷基、S-芳基烷基、NH-芳基烷基、
氨基、N-邻苯二甲
酰亚胺基、
咪唑基、
叠氮基、
肼基、
羟胺基、
异氰酸酯基、亚砜基、磺酰基、
硫醚基、二
硫化物基、
硅烷基、芳基、杂环、碳环、插入剂、报告分子、共轭物、
多胺、多酰胺、多烷基氧基、多醚、增强寡核苷酸药效学性质的基团或增强寡核苷酸药代动力学性质的基团;n为0到约6的整数。